Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 548.00
+2.70 (0.50%)
Apr 21, 2026, 2:09 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 27.66 billion as of April 20, 2026. Its market cap has decreased by -29.83% in one year.
Market Cap
27.66B
Enterprise Value
28.99B
Revenue
8.11B
Ranking
n/a
PE Ratio
144.64
Stock Price
548.00
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 27.66B, an increase of 3,702.46%. That is a compound annual growth rate of 94.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 27.66B | -28.15% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sudeep Pharma | 72.90B |
| Aarti Pharmalabs | 63.26B |
| Sun Pharma Advanced Research Company | 48.03B |
| Innova Captab | 42.48B |
| RPG Life Sciences | 33.48B |
| Solara Active Pharma Sciences | 24.04B |
| Indoco Remedies | 20.27B |
| Windlas Biotech | 18.27B |